Sun Pharmaceutical To Start Generic Protonix Sales in U.S.

NEW DELHI - India's Sun Pharmaceutical said it would immediately begin sales of a generic version of Wyeth's heartburn drug Protonix (pantoprazole) in the U.S., a move expected to be matched by Israel's Teva Laboratories for a market estimated at $2.3 billion